Clinical Trials Directory

Trials / Completed

CompletedNCT00326066

A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients.

A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Newly Diagnosed Open Angle Glaucoma and Subjects Diagnosed With Ocular Hypertension

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
47 (actual)
Sponsor
Glaukos Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety and efficacy of the iStent trabecular micro-bypass stent in reducing intraocular pressure (IOP) in subjects with newly diagnosed open-angle glaucoma and subjects diagnosed with Ocular hypertension.

Detailed description

The study will compare the reduction in IOP of those subjects implanted with two Glaukos micro-stents with the reduction in IOP for patients receiving only primary medical therapy (Xalatan - Latanoprost) or cataract surgery alone. Both groups will undergo routine cataract surgery.

Conditions

Interventions

TypeNameDescription
DEVICEGlaucoma SurgeryComparing the effect in reducing IOP with two Trabecular Bypass Microstents Versus none in patients undergoing cataract surgery, with early open angle glaucoma or ocular hypertension.
PROCEDUREcataract surgery onlySubjects will undergo routine cataract surgery only (no stent implant).

Timeline

Start date
2005-02-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2006-05-16
Last updated
2018-03-09

Locations

9 sites across 5 countries: Austria, Germany, Netherlands, Spain, Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT00326066. Inclusion in this directory is not an endorsement.